Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 medications, according to the ...

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

The Centers for Medicare & Medicaid Services will provide eligible Medicare beneficiaries monthly access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

Leading Republicans are looking toward the Government Accountability Office (GAO) to ensure CMS' new premium stabilization demonstration program is legal and in the best interest of seniors. In a ...

The CMS Innovation Center will terminate four Medicare payment models early in a move that aims to save nearly $750 million and shift focus to more viable approaches to value-based care. CMS said the ...

Using section 1115 waivers, states can test different approaches to managing their Medicaid programs, in a bid to give states flexibility to improve the safety-net programs. The CMS has previously ...

CMS has published a list of 202 measures under consideration for use in hospitals and other Medicare public reporting and payment programs. In publishing the list, CMS will be able to gain input on ...